Company Diamyd Medical AB Nasdaq Stockholm

Equities

Biotechnology & Medical Research

Business Summary

Share class

Company contact information

Sector

Sector Other Biotechnology & Medical Research

Inactive Instrument

End-of-day quote Nasdaq Stockholm Other stock markets
- ^SEK	-

2017	Sanofi Pasteur Inc. completed the acquisition of Protein Sciences Corporation from Mertiva AB (NGM:MERT MTF A), Ropart Asset Management Funds, Johnson & Johnson, Pfizer Inc. and others.	CI
2017	Diamyd Medical and Cardiff University to Collaborate on Study Monitoring Immune Response in Lymph Node Cells After Administration of Diamyd	CI

Mertiva AB, formerly Diamyd Medical AB, is a Sweden-based company active within the healthcare sector. As of August 31, 2013, the Company owned 8% shares of the United-States based Protein Sciences Corporation, as well as 19% shares of Mercodia AB. The Company changed its name in May 2013. Additionally, its subsidiary, Diamyd Therapeutics, was spun off and changed its name to Diamyd Medical.

	Vote	Quantity	Free-Float	Total Float
Stock A	0	4,970,500	0	68.13 %
Stock B	1	1,437,876	0
Stock C	0	13,701,726	13,701,726 ( 100.00 %)

Mertiva AB

Edsviksvägen 89

182 35, Danderyd

http://www.mertiva.se/

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
IQVIA HOLDINGS INC.	+3.13%	42.11B
LONZA GROUP AG	+48.83%	40.08B
MODERNA, INC.	+8.49%	40B
CELLTRION, INC.	-10.82%	26.87B
ICON PUBLIC LIMITED COMPANY	+8.26%	24.58B
ALNYLAM PHARMACEUTICALS, INC.	-23.69%	18.44B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	+1.58%	11.94B
MEDPACE HOLDINGS, INC.	+32.83%	11.66B
UNITED THERAPEUTICS CORPORATION	+6.63%	11.01B

Other Biotechnology & Medical Research